ArticleDrug safety2020

Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC).

Hugo Arlegui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.